Private equity eyes up high-street banks
Carlyle’s bid for Metro may be just an appetiser before the hearty main course, says Matthew Lynn


Anyone walking down the high street over the last few years can hardly fail to have noticed Metro. The upstart brought some much needed pizzaz to the dull world of banks, redesigning its branches to look fresh, modern and vibrant instead of something that might have looked a little dowdy in 1955.
That was nice in its own way, but it hasn’t proved a great business model. Metro only has 1.7 million account holders. Hardly anyone ever goes into a branch any more, so it doesn’t make much difference whether the layout is nice or not. And it is very, very hard to persuade people to switch their accounts. Metro’s shares remain a long way below the 400p they were priced at when the firm listed in 2016.
Enter private-equity group Carlyle, which last week made the opening moves on a takeover of the bank. By the standards of some blow-out deals so far in 2021, this one is relatively small change. Carlyle will have to pay around £250m-£300m if it does take it over. The shares were up by 29% on the day the approach was announced – but still, not a huge business. Carlyle has until the start of next month to table a formal offer to shareholders. If Carlyle does end up buying it, shareholders will no doubt be relieved.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
What’s the appeal?
The buy-out may, though, prove to be just the prelude for a really big deal: a private-equity takeover of one of the high street banks. There are three reasons they might be tempted. First, all the major high-street banks have massive and improving cash flow. We have seen that with their latest round of results. All of them are making big profits, and paying dividends again, and with the economy improving that will continue.
Second, there is plenty of scope for cost savings. All the major banks still have far too many branches for the level of demand, and the costs of keeping those open are huge. IT systems are antiquated and services are duplicated. It is hard to understand, for example, why they need their own networks of cash machines when so few of us use folding notes anymore.
Finally, there is lots of room for financial engineering, and that is what the buyout firms are really good at. Indeed, one of the main attractions of Metro might be that the private-equity giant can use its balance sheet to raise capital cheaply and then use Metro to make more expensive loans to consumers and small businesses. The margins on that will be very good, but they would be a lot better for one of the big four banks.
Of course there are plenty of obstacles. The Bank of England might say no. Private-equity firms are highly leveraged, and so are banks, so if you put the two together you get leverage squared, and that doesn’t sound like a recipe for financial stability. A takeover could be deemed too risky. And of course there may well be political opposition. All the people who didn’t like buy-out firms bidding for Morrisons will be even more outraged at the prospect of a well-known bank getting taken over. If it involves closing branches, as it almost certainly will, then there will be even more angry voices and the unions will complain about job cuts. An increasingly protectionist government might well block a deal.
The most tempting targets
That doesn’t mean there won’t be an attempt though. If there is, Lloyds would be by far the most tempting target. It is mainly focussed on the UK, its balance sheet has been repaired, and it has a solid customer base. NatWest would be next on the list if the government could be persuaded to sell its remaining 54% shareholding in one go. It has been largely cleaned up during more than a decade of effective state ownership.
Barclays is a lot more complex, because it has both a retail and a wholesale business, although it might well be possible to split it up, which would be an improvement anyway, and to put its retail business into a private-equity firm. HSBC would be a step too far. It is too big and too deeply involved in China.
If the Metro deal goes through over the next couple of months, don’t be surprised if the big buy-out firms move on from the appetiser to the main course.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Matthew Lynn is a columnist for Bloomberg, and writes weekly commentary syndicated in papers such as the Daily Telegraph, Die Welt, the Sydney Morning Herald, the South China Morning Post and the Miami Herald. He is also an associate editor of Spectator Business, and a regular contributor to The Spectator. Before that, he worked for the business section of the Sunday Times for ten years.
He has written books on finance and financial topics, including Bust: Greece, The Euro and The Sovereign Debt Crisis and The Long Depression: The Slump of 2008 to 2031. Matthew is also the author of the Death Force series of military thrillers and the founder of Lume Books, an independent publisher.
-
What will the unravelling of US-China trade mean for the economy?
What will a US-China decoupling mean for the global economy?
-
Scottish Mortgage: why we’re turning to private companies and China for exceptional returns
When it comes to delivering growth, Scottish Mortgage will stop at no end in its hunt for exceptional long-term returns - this includes China, unicorn companies and sectors such as space exploration
-
Two ways to tap into monopoly profits from airports
Most investors can’t get their hands on airports. Here are two ways you can
-
Fat profits: should you invest in weight-loss drugs?
The latest weight-loss treatments could transform public health and the world economy. Should you invest?
-
How investors could profit from Ramsden Holdings' four-part growth strategy
Ramsdens Holdings offers a diversified set of financial and retail services and a juicy yield, says Dr Michael Tubbs
-
How to invest in the booming insurance market
The insurance sector is experiencing rapid growth after years of stagnation. Smart investors should buy in now, says Rupert Hargreaves
-
Why the 'Great Rotation' away from US assets will boost Britain
Opinion Disenchanted investors have only just begun to withdraw capital from America, says Jeremy McKeown.
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocks
Opinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money